APO Research
Talk to an analyst

APO RESEARCH · REPORT

Digital Therapeutics Platforms for Mental Health

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Digital Therapeutics Platforms for Mental Health Market Outlook and Growth Opportunities 2026

6 March 2026210 pages

Choose your research edition.

Industry ResearchDigital Therapeutics Platforms for Mental Health Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Therapeutics Platforms for Mental Health Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Digital Therapeutics Platforms for Mental Health Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Therapeutics Platforms for Mental Health Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Therapeutics Platforms for Mental Health Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Digital Therapeutics Platforms for Mental Health market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Digital Therapeutics Platforms for Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digital Therapeutics Platforms for Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Therapeutics Platforms for Mental Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Digital Therapeutics Platforms for Mental Health market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Digital Therapeutics Platforms for Mental Health market include Akili Interactive, Teladoc Health, Talkspace, CogniFit, Orexo, SilverCloud (Amwell), Noom, Big Health and Cognoa, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Digital Therapeutics Platforms for Mental Health market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digital Therapeutics Platforms for Mental Health and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digital Therapeutics Platforms for Mental Health revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Digital Therapeutics Platforms for Mental Health market.

Digital Therapeutics Platforms for Mental Health Segment by Company

Akili Interactive

Teladoc Health

Talkspace

CogniFit

Orexo

SilverCloud (Amwell)

Noom

Big Health

Cognoa

Headspace Health

Calm Health

Lark Health

Vida Health

Mahana Therapeutics

Blue Note Therapeutics

Lyra Health

Modern Health

Canary Health

Woebot Health

LifeStance Health

Cerebral

MoodMission

Youper

Best Covered

Dami and Xiaomi

WeiMai

Digital Therapeutics Platforms for Mental Health Segment by Type

Apps

Online Platforms

Digital Therapeutics Platforms for Mental Health Segment by Application

Enterprise

Personal

Digital Therapeutics Platforms for Mental Health Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Digital Therapeutics Platforms for Mental Health status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Digital Therapeutics Platforms for Mental Health key companies, revenue, market share, and recent developments.

3. To split the Digital Therapeutics Platforms for Mental Health breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Digital Therapeutics Platforms for Mental Health market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Digital Therapeutics Platforms for Mental Health significant trends, drivers, influence factors in global and regions.

6. To analyze Digital Therapeutics Platforms for Mental Health competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics Platforms for Mental Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics Platforms for Mental Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics Platforms for Mental Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digital Therapeutics Platforms for Mental Health industry.

Chapter 3: Detailed analysis of Digital Therapeutics Platforms for Mental Health company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Digital Therapeutics Platforms for Mental Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Digital Therapeutics Platforms for Mental Health in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Digital Therapeutics Platforms for Mental Health Industry Trends Table 2. Digital Therapeutics Platforms for Mental Health Industry Drivers Table 3. Digital Therapeutics Platforms for Mental Health Industry Opportunities and Challenges Table 4. Digital Therapeutics Platforms for Mental Health Industry Restraints Table 5. Global Digital Therapeutics Platforms for Mental Health Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Digital Therapeutics Platforms for Mental Health Revenue Share by Company (2021-2026) Table 7. Global Digital Therapeutics Platforms for Mental Health Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Digital Therapeutics Platforms for Mental Health Key Company Manufacturing Base & Headquarters Table 9. Global Digital Therapeutics Platforms for Mental Health Company, Product Type & Application Table 10. Global Digital Therapeutics Platforms for Mental Health Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Digital Therapeutics Platforms for Mental Health by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Apps Table 15. Significant Companies of Online Platforms Table 16. Global Digital Therapeutics Platforms for Mental Health Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Digital Therapeutics Platforms for Mental Health Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Digital Therapeutics Platforms for Mental Health Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Type (2021-2026) Table 20. Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Enterprise Table 22. Significant Companies of Personal Table 23. Global Digital Therapeutics Platforms for Mental Health Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Digital Therapeutics Platforms for Mental Health Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Digital Therapeutics Platforms for Mental Health Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Application (2021-2026) Table 27. Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Application (2027-2032) Table 28. Global Digital Therapeutics Platforms for Mental Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Digital Therapeutics Platforms for Mental Health Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Region (2021-2026) Table 31. Global Digital Therapeutics Platforms for Mental Health Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Region (2027-2032) Table 33. Global Digital Therapeutics Platforms for Mental Health Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Digital Therapeutics Platforms for Mental Health Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Digital Therapeutics Platforms for Mental Health Sales Value Market Share by Country (2021-2026) Table 36. Global Digital Therapeutics Platforms for Mental Health Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Digital Therapeutics Platforms for Mental Health Sales Value Market Share by Country (2027-2032) Table 38. Akili Interactive Company Information Table 39. Akili Interactive Business Overview Table 40. Akili Interactive Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Akili Interactive Digital Therapeutics Platforms for Mental Health Product Portfolio Table 42. Akili Interactive Recent Development Table 43. Teladoc Health Company Information Table 44. Teladoc Health Business Overview Table 45. Teladoc Health Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Teladoc Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 47. Teladoc Health Recent Development Table 48. Talkspace Company Information Table 49. Talkspace Business Overview Table 50. Talkspace Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Talkspace Digital Therapeutics Platforms for Mental Health Product Portfolio Table 52. Talkspace Recent Development Table 53. CogniFit Company Information Table 54. CogniFit Business Overview Table 55. CogniFit Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. CogniFit Digital Therapeutics Platforms for Mental Health Product Portfolio Table 57. CogniFit Recent Development Table 58. Orexo Company Information Table 59. Orexo Business Overview Table 60. Orexo Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Orexo Digital Therapeutics Platforms for Mental Health Product Portfolio Table 62. Orexo Recent Development Table 63. SilverCloud (Amwell) Company Information Table 64. SilverCloud (Amwell) Business Overview Table 65. SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Product Portfolio Table 67. SilverCloud (Amwell) Recent Development Table 68. Noom Company Information Table 69. Noom Business Overview Table 70. Noom Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Noom Digital Therapeutics Platforms for Mental Health Product Portfolio Table 72. Noom Recent Development Table 73. Big Health Company Information Table 74. Big Health Business Overview Table 75. Big Health Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Big Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 77. Big Health Recent Development Table 78. Cognoa Company Information Table 79. Cognoa Business Overview Table 80. Cognoa Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Cognoa Digital Therapeutics Platforms for Mental Health Product Portfolio Table 82. Cognoa Recent Development Table 83. Headspace Health Company Information Table 84. Headspace Health Business Overview Table 85. Headspace Health Digital Therapeutics Platforms for Mental Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Headspace Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 87. Headspace Health Recent Development Table 88. Calm Health Company Information Table 89. Calm Health Business Overview Table 90. Calm Health Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Calm Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 92. Calm Health Recent Development Table 93. Lark Health Company Information Table 94. Lark Health Business Overview Table 95. Lark Health Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Lark Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 97. Lark Health Recent Development Table 98. Vida Health Company Information Table 99. Vida Health Business Overview Table 100. Vida Health Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Vida Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 102. Vida Health Recent Development Table 103. Mahana Therapeutics Company Information Table 104. Mahana Therapeutics Business Overview Table 105. Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Product Portfolio Table 107. Mahana Therapeutics Recent Development Table 108. Blue Note Therapeutics Company Information Table 109. Blue Note Therapeutics Business Overview Table 110. Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Product Portfolio Table 112. Blue Note Therapeutics Recent Development Table 113. Lyra Health Company Information Table 114. Lyra Health Business Overview Table 115. Lyra Health Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Lyra Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 117. Lyra Health Recent Development Table 118. Modern Health Company Information Table 119. Modern Health Business Overview Table 120. Modern Health Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Modern Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 122. Modern Health Recent Development Table 123. Canary Health Company Information Table 124. Canary Health Business Overview Table 125. Canary Health Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Canary Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 127. Canary Health Recent Development Table 128. Woebot Health Company Information Table 129. Woebot Health Business Overview Table 130. Woebot Health Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Woebot Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 132. Woebot Health Recent Development Table 133. LifeStance Health Company Information Table 134. LifeStance Health Business Overview Table 135. LifeStance Health Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. LifeStance Health Digital Therapeutics Platforms for Mental Health Product Portfolio Table 137. LifeStance Health Recent Development Table 138. Cerebral Company Information Table 139. Cerebral Business Overview Table 140. Cerebral Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Cerebral Digital Therapeutics Platforms for Mental Health Product Portfolio Table 142. Cerebral Recent Development Table 143. MoodMission Company Information Table 144. MoodMission Business Overview Table 145. MoodMission Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. MoodMission Digital Therapeutics Platforms for Mental Health Product Portfolio Table 147. MoodMission Recent Development Table 148. Youper Company Information Table 149. Youper Business Overview Table 150. Youper Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Youper Digital Therapeutics Platforms for Mental Health Product Portfolio Table 152. Youper Recent Development Table 153. Best Covered Company Information Table 154. Best Covered Business Overview Table 155. Best Covered Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Best Covered Digital Therapeutics Platforms for Mental Health Product Portfolio Table 157. Best Covered Recent Development Table 158. Dami and Xiaomi Company Information Table 159. Dami and Xiaomi Business Overview Table 160. Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Product Portfolio Table 162. Dami and Xiaomi Recent Development Table 163. WeiMai Company Information Table 164. WeiMai Business Overview Table 165. WeiMai Digital Therapeutics Platforms for Mental Health Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. WeiMai Digital Therapeutics Platforms for Mental Health Product Portfolio Table 167. WeiMai Recent Development Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Digital Therapeutics Platforms for Mental Health Product Image Figure 2. Global Digital Therapeutics Platforms for Mental Health Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Therapeutics Platforms for Mental Health Market Size (2021-2032) & (US$ Million) Figure 4. Global Digital Therapeutics Platforms for Mental Health Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Apps Image Figure 8. Online Platforms Image Figure 9. Global Digital Therapeutics Platforms for Mental Health Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Digital Therapeutics Platforms for Mental Health Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Type (2021-2032) Figure 12. Enterprise Image Figure 13. Personal Image Figure 14. Global Digital Therapeutics Platforms for Mental Health Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Digital Therapeutics Platforms for Mental Health Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Application (2021-2032) Figure 17. Global Digital Therapeutics Platforms for Mental Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 20. North America Digital Therapeutics Platforms for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Digital Therapeutics Platforms for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Digital Therapeutics Platforms for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 26. South America Digital Therapeutics Platforms for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Digital Therapeutics Platforms for Mental Health Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Apps
  • Online Platforms
Applications
  • Enterprise
  • Personal
Companies covered
  • Akili Interactive
  • Teladoc Health
  • Talkspace
  • CogniFit
  • Orexo
  • SilverCloud (Amwell)
  • Noom
  • Big Health
  • Cognoa
  • Headspace Health
  • Calm Health
  • Lark Health
  • Vida Health
  • Mahana Therapeutics
  • Blue Note Therapeutics
  • Lyra Health
  • Modern Health
  • Canary Health
  • Woebot Health
  • LifeStance Health
  • Cerebral
  • MoodMission
  • Youper
  • Best Covered
  • Dami and Xiaomi
  • WeiMai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Digital Therapeutics Platforms for Mental Health Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Digital Therapeutics Platforms for Mental Health Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Digital Therapeutics Platforms for Mental Health Market Dynamics
  1. 2.1 Digital Therapeutics Platforms for Mental Health Industry Trends
  2. 2.2 Digital Therapeutics Platforms for Mental Health Industry Drivers
  3. 2.3 Digital Therapeutics Platforms for Mental Health Industry Opportunities and Challenges
  4. 2.4 Digital Therapeutics Platforms for Mental Health Industry Restraints
3 Digital Therapeutics Platforms for Mental Health Market by Company
  1. 3.1 Global Digital Therapeutics Platforms for Mental Health Company Revenue Ranking in 2025
  2. 3.2 Global Digital Therapeutics Platforms for Mental Health Revenue by Company (2021-2026)
  3. 3.3 Global Digital Therapeutics Platforms for Mental Health Company Ranking (2024-2026)
  4. 3.4 Global Digital Therapeutics Platforms for Mental Health Company Manufacturing Base and Headquarters
  5. 3.5 Global Digital Therapeutics Platforms for Mental Health Company Product Type and Application
  6. 3.6 Global Digital Therapeutics Platforms for Mental Health Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Digital Therapeutics Platforms for Mental Health Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Digital Therapeutics Platforms for Mental Health Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Digital Therapeutics Platforms for Mental Health Market by Type
  1. 4.1 Digital Therapeutics Platforms for Mental Health Type Introduction
  2. 4.1.1 Apps
  3. 4.1.2 Online Platforms
  4. 4.2 Global Digital Therapeutics Platforms for Mental Health Sales Value by Type
  5. 4.2.1 Global Digital Therapeutics Platforms for Mental Health Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Digital Therapeutics Platforms for Mental Health Sales Value by Type (2021-2032)
  7. 4.2.3 Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Type (2021-2032)
5 Digital Therapeutics Platforms for Mental Health Market by Application
  1. 5.1 Digital Therapeutics Platforms for Mental Health Application Introduction
  2. 5.1.1 Enterprise
  3. 5.1.2 Personal
  4. 5.2 Global Digital Therapeutics Platforms for Mental Health Sales Value by Application
  5. 5.2.1 Global Digital Therapeutics Platforms for Mental Health Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Digital Therapeutics Platforms for Mental Health Sales Value by Application (2021-2032)
  7. 5.2.3 Global Digital Therapeutics Platforms for Mental Health Sales Value Share by Application (2021-2032)
6 Digital Therapeutics Platforms for Mental Health Regional Value Analysis
  1. 6.1 Global Digital Therapeutics Platforms for Mental Health Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Digital Therapeutics Platforms for Mental Health Sales Value by Region (2021-2032)
  3. 6.2.1 Global Digital Therapeutics Platforms for Mental Health Sales Value by Region: 2021-2026
  4. 6.2.2 Global Digital Therapeutics Platforms for Mental Health Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032)
  7. 6.3.2 North America Digital Therapeutics Platforms for Mental Health Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032)
  10. 6.4.2 Europe Digital Therapeutics Platforms for Mental Health Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Digital Therapeutics Platforms for Mental Health Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032)
  16. 6.6.2 South America Digital Therapeutics Platforms for Mental Health Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Digital Therapeutics Platforms for Mental Health Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Digital Therapeutics Platforms for Mental Health Sales Value Share by Country, 2025 VS 2032
7 Digital Therapeutics Platforms for Mental Health Country-level Value Analysis
  1. 7.1 Global Digital Therapeutics Platforms for Mental Health Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Digital Therapeutics Platforms for Mental Health Sales Value by Country (2021-2032)
  3. 7.2.1 Global Digital Therapeutics Platforms for Mental Health Sales Value by Country (2021-2026)
  4. 7.2.2 Global Digital Therapeutics Platforms for Mental Health Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Digital Therapeutics Platforms for Mental Health Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Digital Therapeutics Platforms for Mental Health Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Digital Therapeutics Platforms for Mental Health Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Akili Interactive
  2. 8.1.1 Akili Interactive Company Information
  3. 8.1.2 Akili Interactive Business Overview
  4. 8.1.3 Akili Interactive Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akili Interactive Digital Therapeutics Platforms for Mental Health Product Portfolio
  6. 8.1.5 Akili Interactive Recent Developments
  7. 8.2 Teladoc Health
  8. 8.2.1 Teladoc Health Company Information
  9. 8.2.2 Teladoc Health Business Overview
  10. 8.2.3 Teladoc Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teladoc Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  12. 8.2.5 Teladoc Health Recent Developments
  13. 8.3 Talkspace
  14. 8.3.1 Talkspace Company Information
  15. 8.3.2 Talkspace Business Overview
  16. 8.3.3 Talkspace Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Talkspace Digital Therapeutics Platforms for Mental Health Product Portfolio
  18. 8.3.5 Talkspace Recent Developments
  19. 8.4 CogniFit
  20. 8.4.1 CogniFit Company Information
  21. 8.4.2 CogniFit Business Overview
  22. 8.4.3 CogniFit Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CogniFit Digital Therapeutics Platforms for Mental Health Product Portfolio
  24. 8.4.5 CogniFit Recent Developments
  25. 8.5 Orexo
  26. 8.5.1 Orexo Company Information
  27. 8.5.2 Orexo Business Overview
  28. 8.5.3 Orexo Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Orexo Digital Therapeutics Platforms for Mental Health Product Portfolio
  30. 8.5.5 Orexo Recent Developments
  31. 8.6 SilverCloud (Amwell)
  32. 8.6.1 SilverCloud (Amwell) Company Information
  33. 8.6.2 SilverCloud (Amwell) Business Overview
  34. 8.6.3 SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SilverCloud (Amwell) Digital Therapeutics Platforms for Mental Health Product Portfolio
  36. 8.6.5 SilverCloud (Amwell) Recent Developments
  37. 8.7 Noom
  38. 8.7.1 Noom Company Information
  39. 8.7.2 Noom Business Overview
  40. 8.7.3 Noom Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Noom Digital Therapeutics Platforms for Mental Health Product Portfolio
  42. 8.7.5 Noom Recent Developments
  43. 8.8 Big Health
  44. 8.8.1 Big Health Company Information
  45. 8.8.2 Big Health Business Overview
  46. 8.8.3 Big Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Big Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  48. 8.8.5 Big Health Recent Developments
  49. 8.9 Cognoa
  50. 8.9.1 Cognoa Company Information
  51. 8.9.2 Cognoa Business Overview
  52. 8.9.3 Cognoa Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cognoa Digital Therapeutics Platforms for Mental Health Product Portfolio
  54. 8.9.5 Cognoa Recent Developments
  55. 8.10 Headspace Health
  56. 8.10.1 Headspace Health Company Information
  57. 8.10.2 Headspace Health Business Overview
  58. 8.10.3 Headspace Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Headspace Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  60. 8.10.5 Headspace Health Recent Developments
  61. 8.11 Calm Health
  62. 8.11.1 Calm Health Company Information
  63. 8.11.2 Calm Health Business Overview
  64. 8.11.3 Calm Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Calm Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  66. 8.11.5 Calm Health Recent Developments
  67. 8.12 Lark Health
  68. 8.12.1 Lark Health Company Information
  69. 8.12.2 Lark Health Business Overview
  70. 8.12.3 Lark Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lark Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  72. 8.12.5 Lark Health Recent Developments
  73. 8.13 Vida Health
  74. 8.13.1 Vida Health Company Information
  75. 8.13.2 Vida Health Business Overview
  76. 8.13.3 Vida Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Vida Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  78. 8.13.5 Vida Health Recent Developments
  79. 8.14 Mahana Therapeutics
  80. 8.14.1 Mahana Therapeutics Company Information
  81. 8.14.2 Mahana Therapeutics Business Overview
  82. 8.14.3 Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Mahana Therapeutics Digital Therapeutics Platforms for Mental Health Product Portfolio
  84. 8.14.5 Mahana Therapeutics Recent Developments
  85. 8.15 Blue Note Therapeutics
  86. 8.15.1 Blue Note Therapeutics Company Information
  87. 8.15.2 Blue Note Therapeutics Business Overview
  88. 8.15.3 Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Blue Note Therapeutics Digital Therapeutics Platforms for Mental Health Product Portfolio
  90. 8.15.5 Blue Note Therapeutics Recent Developments
  91. 8.16 Lyra Health
  92. 8.16.1 Lyra Health Company Information
  93. 8.16.2 Lyra Health Business Overview
  94. 8.16.3 Lyra Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Lyra Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  96. 8.16.5 Lyra Health Recent Developments
  97. 8.17 Modern Health
  98. 8.17.1 Modern Health Company Information
  99. 8.17.2 Modern Health Business Overview
  100. 8.17.3 Modern Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Modern Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  102. 8.17.5 Modern Health Recent Developments
  103. 8.18 Canary Health
  104. 8.18.1 Canary Health Company Information
  105. 8.18.2 Canary Health Business Overview
  106. 8.18.3 Canary Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Canary Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  108. 8.18.5 Canary Health Recent Developments
  109. 8.19 Woebot Health
  110. 8.19.1 Woebot Health Company Information
  111. 8.19.2 Woebot Health Business Overview
  112. 8.19.3 Woebot Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Woebot Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  114. 8.19.5 Woebot Health Recent Developments
  115. 8.20 LifeStance Health
  116. 8.20.1 LifeStance Health Company Information
  117. 8.20.2 LifeStance Health Business Overview
  118. 8.20.3 LifeStance Health Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  119. 8.20.4 LifeStance Health Digital Therapeutics Platforms for Mental Health Product Portfolio
  120. 8.20.5 LifeStance Health Recent Developments
  121. 8.21 Cerebral
  122. 8.21.1 Cerebral Company Information
  123. 8.21.2 Cerebral Business Overview
  124. 8.21.3 Cerebral Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Cerebral Digital Therapeutics Platforms for Mental Health Product Portfolio
  126. 8.21.5 Cerebral Recent Developments
  127. 8.22 MoodMission
  128. 8.22.1 MoodMission Company Information
  129. 8.22.2 MoodMission Business Overview
  130. 8.22.3 MoodMission Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  131. 8.22.4 MoodMission Digital Therapeutics Platforms for Mental Health Product Portfolio
  132. 8.22.5 MoodMission Recent Developments
  133. 8.23 Youper
  134. 8.23.1 Youper Company Information
  135. 8.23.2 Youper Business Overview
  136. 8.23.3 Youper Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Youper Digital Therapeutics Platforms for Mental Health Product Portfolio
  138. 8.23.5 Youper Recent Developments
  139. 8.24 Best Covered
  140. 8.24.1 Best Covered Company Information
  141. 8.24.2 Best Covered Business Overview
  142. 8.24.3 Best Covered Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Best Covered Digital Therapeutics Platforms for Mental Health Product Portfolio
  144. 8.24.5 Best Covered Recent Developments
  145. 8.25 Dami and Xiaomi
  146. 8.25.1 Dami and Xiaomi Company Information
  147. 8.25.2 Dami and Xiaomi Business Overview
  148. 8.25.3 Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Dami and Xiaomi Digital Therapeutics Platforms for Mental Health Product Portfolio
  150. 8.25.5 Dami and Xiaomi Recent Developments
  151. 8.26 WeiMai
  152. 8.26.1 WeiMai Company Information
  153. 8.26.2 WeiMai Business Overview
  154. 8.26.3 WeiMai Digital Therapeutics Platforms for Mental Health Revenue and Gross Margin (2021-2026)
  155. 8.26.4 WeiMai Digital Therapeutics Platforms for Mental Health Product Portfolio
  156. 8.26.5 WeiMai Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst